• 38 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Profile The profile is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
NF-E2-Related Factor 2 Medicine & Life Sciences
Antioxidant Response Elements Medicine & Life Sciences
Anti-Inflammatory Agents Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2019

Publications 1999 2018

  • 38 h-Index
  • 86 Article
  • 1 Editorial
  • 1 Review article
1 Citations

A BET bromodomain inhibitor suppresses adiposity-associated malignant transformation

Chakraborty, D., Benham, V., Jdanov, V., Bullard, B., Leal, A. S., Liby, K. T. & Bernard, J. J. Mar 1 2018 In : Cancer Prevention Research. 11, 3, p. 129-142 14 p.

Research output: Contribution to journalArticle

Intra-Abdominal Fat
Adiposity
Fibroblast Growth Factor 2
Neoplasms
High Fat Diet
1 Citations

Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762

Zhang, D., Leal, A. S., Carapellucci, S., Zydeck, K., Sporn, M. B. & Liby, K. T. Mar 1 2018 In : Cancer Prevention Research. 11, 3, p. 143-156 14 p.

Research output: Contribution to journalArticle

Chemoprevention
Lung Neoplasms
Breast Neoplasms
Neoplasms
Cellular Microenvironment
1 Citations

Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation

Zagorski, J. W., Turley, A. E., Freeborn, R. A., VanDenBerg, K. R., Dover, H. E., Kardell, B. R., Liby, K. T. & Rockwell, C. E. Jan 1 2018 In : Biochemical Pharmacology. 147, p. 67-76 10 p.

Research output: Contribution to journalArticle

T-cells
Interleukin-2
Chemical activation
T-Lymphocytes
Transcription Factor AP-1
6 Citations

Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer

Leal, A. S., Williams, C. R., Royce, D. B., Pioli, P. A., Sporn, M. B. & Liby, K. T. May 28 2017 In : Cancer Letters. 394, p. 76-87 12 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Proteins
Therapeutics
cdc Genes
Tumor Microenvironment

Design, synthesis, and biological activity of second-generation synthetic oleanane triterpenoids

Fu, L., Lin, Q. X., Onyango, E. O., Liby, K. T., Sporn, M. B. & Gribble, G. W. 2017 In : Organic and Biomolecular Chemistry. 15, 28, p. 6001-6005 5 p.

Research output: Contribution to journalArticle

activity (biology)
Bioactivity
amides
Amides
synthesis